VALACYCLOVIR

VALACYCLOVIR was reported 71570 times

VALACYCLOVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 32 0.1633
1 MULTISYSTEM INFLAMMATORY SYNDROME 24 0.1387
2 HUMAN HERPESVIRUS 6 ENCEPHALITIS 26 0.0915
3 MICROSPORIDIA INFECTION 28 0.0798
4 MANTLE CELL LYMPHOMA RECURRENT 34 0.0782
5 OPHTHALMIC HERPES SIMPLEX 39 0.0677
6 KLEBSIELLA BACTERAEMIA 52 0.0547
7 RESPIRATORY TRACT INFECTION BACTERIAL 26 0.0522
8 PERIORBITAL PAIN 44 0.0519
9 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 27 0.0449
10 CRYSTALLURIA 24 0.0441
11 CYTOKINE RELEASE SYNDROME 871 0.0434
12 NECROTISING RETINITIS 27 0.0422
13 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 39 0.0422
14 HEPATIC CYTOLYSIS 497 0.0389
15 FEBRILE BONE MARROW APLASIA 163 0.0383
16 STREPTOCOCCAL BACTERAEMIA 41 0.0377
17 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 208 0.0351
18 PSEUDOMONAL BACTERAEMIA 27 0.0316
19 BONE DEMINERALISATION 33 0.0312
20 ESCHERICHIA BACTERAEMIA 72 0.0306
21 APLASTIC ANAEMIA 152 0.0291
22 HERPES OPHTHALMIC 38 0.0287
23 GENITAL HERPES 44 0.0287
24 DILATED CARDIOMYOPATHY 28 0.0277
25 EYELID PAIN 56 0.0275
26 HERPES VIRUS INFECTION 156 0.0271
27 IMMUNOGLOBULINS DECREASED 37 0.0269
28 MIXED LIVER INJURY 81 0.0269
29 HERPES SIMPLEX 174 0.0267
30 TOXIC ENCEPHALOPATHY 131 0.0258
31 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 55 0.0258
32 APLASIA 50 0.0255
33 FEBRILE NEUTROPENIA 1687 0.0254
34 NEUROTOXICITY 445 0.0254
35 OPHTHALMIC HERPES ZOSTER 44 0.0244
36 PNEUMONIA INFLUENZAL 29 0.0243
37 CHOLESTATIC LIVER INJURY 52 0.0233
38 DERMATITIS EXFOLIATIVE GENERALISED 81 0.0233
39 RHINOVIRUS INFECTION 85 0.0218
40 BLOOD PRESSURE DIASTOLIC ABNORMAL 54 0.0212
41 MANTLE CELL LYMPHOMA 32 0.0210
42 DIFFUSE LARGE B-CELL LYMPHOMA 162 0.0210
43 PARAINFLUENZAE VIRUS INFECTION 31 0.0204
44 RECTAL PROLAPSE 24 0.0199
45 VARICELLA ZOSTER VIRUS INFECTION 41 0.0198
46 PLATELET TRANSFUSION 25 0.0194
47 POST HERPETIC NEURALGIA 27 0.0188
48 AGRANULOCYTOSIS 347 0.0187
49 BLOOD PRESSURE SYSTOLIC ABNORMAL 45 0.0182
50 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 466 0.0181
51 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 140 0.0180
52 ORAL HERPES 349 0.0179
53 BICYTOPENIA 35 0.0178
54 VACCINATION FAILURE 29 0.0174
55 SQUAMOUS CELL CARCINOMA OF SKIN 105 0.0174
56 ESCHERICHIA SEPSIS 50 0.0172
57 RASH MACULO-PAPULAR 382 0.0172
58 INTENSIVE CARE 24 0.0169
59 RESPIRATORY TRACT INFECTION VIRAL 39 0.0167
60 PLASMA CELL MYELOMA RECURRENT 54 0.0166
61 FEAR OF DISEASE 29 0.0163
62 HYPERURICAEMIA 67 0.0163
63 OPTIC NEUROPATHY 34 0.0161
64 COVID-19 PNEUMONIA 179 0.0151
65 EYELID IRRITATION 38 0.0151
66 HYPOGAMMAGLOBULINAEMIA 99 0.0151
67 RENAL TUBULAR DISORDER 42 0.0149
68 CUTANEOUS VASCULITIS 54 0.0148
69 HYPERPHOSPHATAEMIA 31 0.0144
70 CYTOPENIA 173 0.0141
71 STAPHYLOCOCCAL BACTERAEMIA 61 0.0140
72 ACUTE MYELOID LEUKAEMIA RECURRENT 30 0.0140
73 PLASMACYTOMA 26 0.0140
74 PSEUDOMONAS INFECTION 119 0.0139
75 HERPES ZOSTER 794 0.0138
76 CYTOMEGALOVIRUS INFECTION REACTIVATION 61 0.0138
77 CHOLESTASIS 264 0.0137
78 INFUSION SITE DISCHARGE 24 0.0137
79 POLYMYOSITIS 24 0.0136
80 BRONCHOPULMONARY ASPERGILLOSIS 105 0.0135
81 NEUTROPENIC COLITIS 28 0.0135
82 ACTINIC KERATOSIS 34 0.0131
83 CHRONIC LYMPHOCYTIC LEUKAEMIA 62 0.0131
84 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 98 0.0130
85 TUMOUR LYSIS SYNDROME 113 0.0128
86 PLASMA CELL MYELOMA 492 0.0126
87 EMPYEMA 25 0.0126
88 LYMPHOCYTOSIS 27 0.0125
89 BLOOD IMMUNOGLOBULIN G DECREASED 31 0.0125
90 PNEUMONIA FUNGAL 49 0.0124
91 MUCORMYCOSIS 32 0.0123
92 CYTOMEGALOVIRUS CHORIORETINITIS 24 0.0123
93 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 34 0.0123
94 GRAFT VERSUS HOST DISEASE IN SKIN 27 0.0122
95 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 61 0.0120
96 BACTERAEMIA 141 0.0119
97 GRAFT VERSUS HOST DISEASE 85 0.0118
98 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 28 0.0118
99 ACUTE PULMONARY OEDEMA 66 0.0117
100 LICHENOID KERATOSIS 26 0.0114
101 LYMPHOPENIA 159 0.0112
102 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 26 0.0112
103 ASPERGILLUS INFECTION 73 0.0111
104 TOXIC SKIN ERUPTION 111 0.0110
105 THROMBOTIC MICROANGIOPATHY 106 0.0109
106 PNEUMONIA VIRAL 34 0.0107
107 CLOSTRIDIUM DIFFICILE COLITIS 110 0.0104
108 NEPHROPATHY TOXIC 116 0.0103
109 TONGUE OEDEMA 39 0.0102
110 EYE PAIN 576 0.0102
111 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 96 0.0100
112 STEM CELL TRANSPLANT 25 0.0100
113 PATHOGEN RESISTANCE 91 0.0100
114 CHRONIC GRAFT VERSUS HOST DISEASE 36 0.0100
115 ULCERATIVE KERATITIS 27 0.0098
116 ACUTE MYELOID LEUKAEMIA 153 0.0098
117 EPSTEIN-BARR VIRUS INFECTION 61 0.0098
118 EOSINOPHILIA 171 0.0097
119 CYTOMEGALOVIRUS INFECTION 162 0.0097
120 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 25 0.0097
121 ENCEPHALOPATHY 237 0.0096
122 ESCHERICHIA INFECTION 79 0.0096
123 SUSPECTED OFF LABEL USE 43 0.0095
124 MUCOSAL INFLAMMATION 249 0.0095
125 NOCARDIOSIS 24 0.0094
126 OCULAR DISCOMFORT 105 0.0093
127 METABOLIC ENCEPHALOPATHY 28 0.0093
128 NEUTROPENIA 1267 0.0093
129 VASCULAR DEVICE INFECTION 42 0.0092
130 HORDEOLUM 40 0.0092
131 LUNG OPACITY 24 0.0091
132 RASH MORBILLIFORM 25 0.0090
133 PANCYTOPENIA 500 0.0089
134 PNEUMONIA BACTERIAL 82 0.0089
135 PRODUCT ADMINISTRATION INTERRUPTED 68 0.0087
136 HYPERTHERMIA 66 0.0086
137 ADENOVIRUS INFECTION 25 0.0086
138 PERIPHERAL SENSORY NEUROPATHY 50 0.0085
139 ANHEDONIA 221 0.0084
140 ENCEPHALITIS 58 0.0084
141 PNEUMOCYSTIS JIROVECII PNEUMONIA 84 0.0084
142 SEASONAL ALLERGY 118 0.0083
143 CYTOMEGALOVIRUS VIRAEMIA 37 0.0083
144 INFUSION SITE PRURITUS 26 0.0082
145 AUTONOMIC NERVOUS SYSTEM IMBALANCE 24 0.0082
146 INCORRECT DOSAGE ADMINISTERED 40 0.0082
147 OSTEOPENIA 123 0.0081
148 THROMBOCYTOPENIA 903 0.0081
149 ORGANISING PNEUMONIA 40 0.0081
150 HYPERREFLEXIA 28 0.0080
151 BK VIRUS INFECTION 27 0.0080
152 CHRONIC SINUSITIS 30 0.0080
153 BACTERIAL SEPSIS 26 0.0080
154 INFUSION SITE SWELLING 50 0.0079
155 SEPTIC SHOCK 345 0.0079
156 ACUTE KIDNEY INJURY 1206 0.0079
157 VIRAL MUTATION IDENTIFIED 29 0.0079
158 PHOTOPHOBIA 148 0.0079
159 APHTHOUS ULCER 61 0.0079
160 ENTEROCOCCAL INFECTION 38 0.0079
161 FOREIGN BODY SENSATION IN EYES 50 0.0078
162 B-CELL LYMPHOMA 26 0.0076
163 ACUTE GRAFT VERSUS HOST DISEASE 35 0.0076
164 IMMUNE THROMBOCYTOPENIA 35 0.0076
165 ACUTE CORONARY SYNDROME 63 0.0076
166 FULL BLOOD COUNT DECREASED 153 0.0076
167 NEUTROPHIL COUNT DECREASED 306 0.0075
168 ENTERITIS 48 0.0075
169 HYPERVOLAEMIA 37 0.0075
170 BONE MARROW FAILURE 152 0.0075
171 ISCHAEMIC STROKE 133 0.0074
172 BLOOD PRESSURE DIASTOLIC DECREASED 55 0.0074
173 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 61 0.0074
174 FACIAL PARALYSIS 63 0.0074
175 SWELLING OF EYELID 46 0.0073
176 TRANSFUSION 76 0.0072
177 RESPIRATORY SYNCYTIAL VIRUS INFECTION 63 0.0072
178 FUNGAL SKIN INFECTION 29 0.0072
179 EYE INFECTION 81 0.0072
180 MULTIPLE ALLERGIES 56 0.0071
181 SQUAMOUS CELL CARCINOMA 67 0.0071
182 LYMPHOCYTE COUNT DECREASED 125 0.0071
183 RASH VESICULAR 34 0.0070
184 INFUSION SITE ERYTHEMA 59 0.0070
185 BASAL CELL CARCINOMA 109 0.0070
186 PURPURA 61 0.0069
187 NEUTROPENIC SEPSIS 49 0.0069
188 HEPATOCELLULAR INJURY 96 0.0068
189 TOXIC EPIDERMAL NECROLYSIS 102 0.0067
190 VENOOCCLUSIVE LIVER DISEASE 33 0.0067
191 HEPATITIS ACUTE 43 0.0066
192 ACUTE RESPIRATORY DISTRESS SYNDROME 116 0.0066
193 DRUG RESISTANCE 168 0.0065
194 FOETAL GROWTH RESTRICTION 39 0.0064
195 PARANASAL SINUS DISCOMFORT 24 0.0063
196 COLITIS MICROSCOPIC 30 0.0063
197 NEUROPATHY PERIPHERAL 601 0.0063
198 UPPER-AIRWAY COUGH SYNDROME 52 0.0063
199 MENINGITIS 42 0.0063
200 CHEILITIS 34 0.0063
201 WHITE BLOOD CELL COUNT ABNORMAL 40 0.0063
202 MENINGITIS ASEPTIC 28 0.0062
203 HYPOCALCAEMIA 118 0.0062
204 KLEBSIELLA INFECTION 31 0.0061
205 HYPERCALCAEMIA 75 0.0061
206 SERUM FERRITIN INCREASED 32 0.0061
207 HALLUCINATION, VISUAL 128 0.0061
208 ECONOMIC PROBLEM 91 0.0060
209 COVID-19 1047 0.0060
210 CYSTITIS HAEMORRHAGIC 24 0.0059
211 MYOSITIS 53 0.0059
212 PLEURISY 35 0.0059
213 SKIN INFECTION 66 0.0059
214 INCORRECT DRUG ADMINISTRATION RATE 25 0.0059
215 OESOPHAGITIS 64 0.0059
216 ORAL CANDIDIASIS 77 0.0058
217 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 60 0.0058
218 RHINITIS ALLERGIC 26 0.0058
219 SARS-COV-2 TEST POSITIVE 77 0.0058
220 PARTIAL SEIZURES 30 0.0057
221 RENAL TUBULAR NECROSIS 56 0.0057
222 ATAXIA 67 0.0056
223 SKIN LESION 154 0.0056
224 NEPHROGENIC ANAEMIA 26 0.0056
225 NEUROLOGICAL SYMPTOM 32 0.0056
226 PLATELET COUNT DECREASED 596 0.0056
227 INTRACRANIAL PRESSURE INCREASED 31 0.0056
228 HYPOPHOSPHATAEMIA 41 0.0055
229 WHITE BLOOD CELL COUNT DECREASED 599 0.0055
230 ATRIAL FLUTTER 44 0.0055
231 HEPATITIS B 33 0.0055
232 ENDOCARDITIS 28 0.0055
233 MYOCLONUS 65 0.0054
234 THERAPY PARTIAL RESPONDER 85 0.0054
235 DEVICE RELATED INFECTION 83 0.0054
236 ARTHRITIS INFECTIVE 25 0.0054
237 EYE DISCHARGE 56 0.0054
238 INFUSION SITE PAIN 69 0.0053
239 RETINAL DETACHMENT 49 0.0053
240 HYPERTRANSAMINASAEMIA 37 0.0053
241 LYMPHOMA 82 0.0053
242 LEUKOPENIA 264 0.0053
243 BRAIN FOG 82 0.0052
244 INJECTION SITE INFLAMMATION 26 0.0052
245 INCREASED TENDENCY TO BRUISE 48 0.0052
246 IMMUNOSUPPRESSION 46 0.0052
247 NECROSIS 29 0.0052
248 ODYNOPHAGIA 31 0.0052
249 MULTIPLE ORGAN DYSFUNCTION SYNDROME 146 0.0051
250 RESPIRATORY TRACT INFECTION 134 0.0051
251 COLITIS 194 0.0051
252 BLOOD LACTATE DEHYDROGENASE INCREASED 80 0.0050
253 FOOD POISONING 27 0.0050
254 VITAMIN D DECREASED 43 0.0050
255 FAILURE TO THRIVE 26 0.0050
256 ANAL INCONTINENCE 45 0.0050
257 C-REACTIVE PROTEIN INCREASED 182 0.0050
258 CHOLANGITIS 31 0.0050
259 IMMUNODEFICIENCY 74 0.0050
260 DISEASE PROGRESSION 585 0.0049
261 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
262 PATHOLOGICAL FRACTURE 25 0.0049
263 EYE INFLAMMATION 47 0.0049
264 CANDIDA INFECTION 83 0.0049
265 NEURALGIA 119 0.0049
266 HYPOALBUMINAEMIA 38 0.0049
267 BLOOD MAGNESIUM DECREASED 42 0.0049
268 MYELODYSPLASTIC SYNDROME 70 0.0048
269 EAR PAIN 94 0.0048
270 SUDDEN DEATH 51 0.0048
271 PNEUMONIA 1559 0.0048
272 SECOND PRIMARY MALIGNANCY 40 0.0048
273 STAPHYLOCOCCAL INFECTION 158 0.0048
274 TACHYPNOEA 65 0.0048
275 HYPOXIA 168 0.0048
276 RED BLOOD CELL COUNT DECREASED 136 0.0048
277 PYREXIA 1626 0.0047
278 PANCREATITIS ACUTE 105 0.0047
279 DYSARTHRIA 175 0.0046
280 POOR VENOUS ACCESS 48 0.0046
281 PRODUCT DISTRIBUTION ISSUE 43 0.0046
282 PLATELET COUNT ABNORMAL 28 0.0046
283 CLOSTRIDIUM DIFFICILE INFECTION 101 0.0046
284 BLOOD PRESSURE FLUCTUATION 111 0.0046
285 UPPER RESPIRATORY TRACT INFECTION 213 0.0046
286 PERIORBITAL SWELLING 26 0.0046
287 ATRIAL FIBRILLATION 445 0.0046
288 DERMATITIS BULLOUS 33 0.0046
289 EAR INFECTION 121 0.0045
290 PAPULE 32 0.0045
291 HYPERBILIRUBINAEMIA 47 0.0045
292 DEAFNESS UNILATERAL 25 0.0045
293 OCULAR HYPERAEMIA 215 0.0045
294 SEPSIS 501 0.0045
295 SINUSITIS 460 0.0045
296 HYPOKALAEMIA 206 0.0045
297 EYE SWELLING 166 0.0045
298 BLOOD PRESSURE SYSTOLIC INCREASED 87 0.0045
299 HYPOPHAGIA 114 0.0045
300 GOUT 80 0.0045
301 SPUTUM DISCOLOURED 42 0.0044
302 PHOTOSENSITIVITY REACTION 73 0.0044
303 STOMATITIS 267 0.0044
304 RASH PUSTULAR 32 0.0044
305 EYE IRRITATION 252 0.0044
306 NEPHROTIC SYNDROME 30 0.0044
307 EJECTION FRACTION DECREASED 68 0.0044
308 HAEMOGLOBIN ABNORMAL 28 0.0043
309 FULL BLOOD COUNT ABNORMAL 46 0.0043
310 SPINAL OSTEOARTHRITIS 38 0.0043
311 PULMONARY THROMBOSIS 47 0.0043
312 LUNG DISORDER 211 0.0043
313 GAMMA-GLUTAMYLTRANSFERASE INCREASED 95 0.0043
314 LABORATORY TEST ABNORMAL 126 0.0043
315 FACIAL PAIN 38 0.0043
316 HOSPICE CARE 42 0.0042
317 VIRAL INFECTION 141 0.0042
318 BACTERIAL INFECTION 79 0.0042
319 PNEUMONITIS 115 0.0042
320 PIGMENTATION DISORDER 26 0.0042
321 INTERSTITIAL LUNG DISEASE 203 0.0042
322 HYPERKALAEMIA 147 0.0042
323 INFUSION SITE EXTRAVASATION 26 0.0042
324 IMPAIRED QUALITY OF LIFE 60 0.0042
325 IMMUNE SYSTEM DISORDER 55 0.0042
326 CONJUNCTIVITIS 77 0.0041
327 HAEMOLYTIC ANAEMIA 37 0.0041
328 GENERALISED OEDEMA 51 0.0041
329 ANAEMIA 784 0.0041
330 BRONCHITIS 304 0.0041
331 LACRIMATION INCREASED 124 0.0041
332 FOLLICULITIS 43 0.0041
333 DISEASE RECURRENCE 195 0.0041
334 INTENTIONAL PRODUCT USE ISSUE 359 0.0041
335 RHINITIS 33 0.0041
336 BLOOD SODIUM DECREASED 77 0.0041
337 RESPIRATORY RATE INCREASED 36 0.0041
338 LYMPHOEDEMA 28 0.0040
339 TOOTH DISORDER 90 0.0040
340 ELECTROLYTE IMBALANCE 47 0.0040
341 INFUSION RELATED REACTION 268 0.0040
342 INFECTION 584 0.0040
343 LEUKAEMIA 38 0.0040
344 TRANSPLANT REJECTION 32 0.0040
345 OSTEOPOROSIS 164 0.0040
346 HEPATITIS CHOLESTATIC 24 0.0040
347 HYPOAESTHESIA ORAL 60 0.0040
348 HEPATOMEGALY 39 0.0040
349 DRY EYE 198 0.0040
350 VASCULITIS 46 0.0039
351 TUBULOINTERSTITIAL NEPHRITIS 74 0.0039
352 MALNUTRITION 44 0.0039
353 PYELONEPHRITIS 34 0.0039
354 CHRONIC KIDNEY DISEASE 298 0.0039
355 GLOMERULAR FILTRATION RATE DECREASED 48 0.0039
356 LYMPHADENOPATHY 138 0.0039
357 DECREASED ACTIVITY 42 0.0039
358 BLOOD CREATININE INCREASED 254 0.0039
359 SINUS DISORDER 77 0.0039
360 ALTERED STATE OF CONSCIOUSNESS 84 0.0039
361 QUALITY OF LIFE DECREASED 52 0.0039
362 APHASIA 117 0.0039
363 BODY TEMPERATURE INCREASED 79 0.0039
364 FUNGAL INFECTION 129 0.0039
365 EMBOLISM 32 0.0038
366 TASTE DISORDER 78 0.0038
367 HAEMATOCRIT DECREASED 76 0.0038
368 CONSTIPATION 835 0.0038
369 GASTROENTERITIS VIRAL 69 0.0038
370 POLYP 25 0.0038
371 MENTAL STATUS CHANGES 106 0.0038
372 NEUTROPHIL COUNT INCREASED 39 0.0038
373 ORAL PAIN 85 0.0038
374 SKIN PLAQUE 32 0.0038
375 PHARYNGITIS 47 0.0038
376 END STAGE RENAL DISEASE 69 0.0038
377 CORONAVIRUS INFECTION 25 0.0038
378 DERMATITIS CONTACT 43 0.0038
379 CONFUSIONAL STATE 607 0.0038
380 CELLULITIS 189 0.0037
381 PLEURAL EFFUSION 228 0.0037
382 FACE OEDEMA 63 0.0037
383 BRONCHIECTASIS 25 0.0037
384 INCOHERENT 24 0.0037
385 LIVE BIRTH 31 0.0037
386 ILEUS 46 0.0037
387 MAJOR DEPRESSION 27 0.0037
388 SCAB 42 0.0037
389 GASTROINTESTINAL INFECTION 33 0.0037
390 SPLENOMEGALY 43 0.0037
391 BLOOD POTASSIUM DECREASED 110 0.0037
392 TENDERNESS 38 0.0036
393 ERYTHEMA MULTIFORME 34 0.0036
394 ARTHROPOD BITE 27 0.0036
395 RENAL FAILURE 483 0.0036
396 SUBDURAL HAEMATOMA 52 0.0036
397 RESPIRATORY DISTRESS 100 0.0036
398 URINARY TRACT INFECTION 615 0.0036
399 INSURANCE ISSUE 55 0.0036
400 SKIN MASS 24 0.0036
401 SKIN LACERATION 39 0.0036
402 DIARRHOEA 2313 0.0036
403 UROSEPSIS 33 0.0036
404 GASTROENTERITIS 52 0.0036
405 ILLNESS 367 0.0036
406 ORTHOSTATIC HYPOTENSION 62 0.0036
407 MOUTH ULCERATION 75 0.0036
408 LOCALISED INFECTION 86 0.0036
409 THERAPY NON-RESPONDER 159 0.0035
410 PRODUCT DOSE OMISSION IN ERROR 100 0.0035
411 PRODUCT ADMINISTRATION ERROR 71 0.0035
412 FOOD ALLERGY 27 0.0035
413 INFLUENZA 390 0.0035
414 BLOOD DISORDER 28 0.0035
415 TOOTH INFECTION 46 0.0035
416 RASH PRURITIC 189 0.0035
417 THERAPY INTERRUPTED 249 0.0035
418 HYDRONEPHROSIS 26 0.0035
419 FOREIGN BODY IN REPRODUCTIVE TRACT 31 0.0035
420 RENAL IMPAIRMENT 291 0.0035
421 RESPIRATORY TRACT CONGESTION 55 0.0035
422 NOCTURIA 42 0.0035
423 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 165 0.0034
424 WRIST FRACTURE 41 0.0034
425 FLANK PAIN 32 0.0034
426 AGEUSIA 85 0.0034
427 RHINORRHOEA 218 0.0034
428 OXYGEN SATURATION DECREASED 189 0.0034
429 HEPATITIS 86 0.0034
430 MUSCULOSKELETAL CHEST PAIN 52 0.0034
431 ANKLE FRACTURE 52 0.0034
432 IRON DEFICIENCY ANAEMIA 31 0.0034
433 DYSPNOEA EXERTIONAL 126 0.0033
434 DERMATITIS 70 0.0033
435 MUSCLE SPASTICITY 41 0.0033
436 MICTURITION URGENCY 38 0.0033
437 CARDIAC FAILURE 266 0.0033
438 SINUS BRADYCARDIA 32 0.0033
439 RIB FRACTURE 68 0.0033
440 IMPAIRED GASTRIC EMPTYING 45 0.0033
441 PRODUCT USE COMPLAINT 52 0.0033
442 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 56 0.0033
443 HICCUPS 27 0.0033
444 STATUS EPILEPTICUS 37 0.0033
445 DISSEMINATED INTRAVASCULAR COAGULATION 46 0.0033
446 PRODUCT SUBSTITUTION ISSUE 188 0.0033
447 ANURIA 28 0.0033
448 DIVERTICULITIS 90 0.0032
449 BONE PAIN 190 0.0032
450 SKIN DISORDER 108 0.0032
451 BLOOD COUNT ABNORMAL 49 0.0032
452 DISORIENTATION 128 0.0032
453 NIGHT SWEATS 104 0.0032
454 OFF LABEL USE 2810 0.0032
455 FATIGUE 2496 0.0032
456 DELIRIUM 111 0.0032
457 SHOCK HAEMORRHAGIC 26 0.0032
458 HYPOTENSION 638 0.0032
459 VITAMIN D DEFICIENCY 31 0.0032
460 UVEITIS 43 0.0032
461 FOOT FRACTURE 60 0.0032
462 PRODUCTIVE COUGH 151 0.0032
463 POOR QUALITY SLEEP 68 0.0032
464 NECK PAIN 176 0.0031
465 DEHYDRATION 419 0.0031
466 LIGAMENT SPRAIN 31 0.0031
467 BIPOLAR DISORDER 34 0.0031
468 MYOPATHY 27 0.0031
469 ANGIOEDEMA 138 0.0031
470 SINUS CONGESTION 42 0.0031
471 DEEP VEIN THROMBOSIS 202 0.0031
472 PRODUCT PRESCRIBING ERROR 74 0.0031
473 NEPHROPATHY 29 0.0031
474 COUGH 871 0.0031
475 CONCUSSION 24 0.0031
476 LIMB INJURY 84 0.0031
477 BRAIN INJURY 31 0.0031
478 DERMATITIS ATOPIC 163 0.0031
479 CATARACT 184 0.0031
480 SPINAL OPERATION 38 0.0031
481 PULMONARY EMBOLISM 293 0.0031
482 PRODUCT DOSE OMISSION ISSUE 905 0.0031
483 CHILLS 360 0.0031
484 PULMONARY HAEMORRHAGE 24 0.0031
485 INFLAMMATION 158 0.0031
486 MALIGNANT MELANOMA 41 0.0031
487 RESPIRATORY FAILURE 223 0.0031
488 THROMBOSIS 246 0.0031
489 FEEDING DISORDER 62 0.0031
490 HYPERTENSIVE CRISIS 34 0.0031
491 RASH 1331 0.0031
492 ASTHENIA 1145 0.0030
493 SPINAL FRACTURE 61 0.0030
494 BLOOD BILIRUBIN INCREASED 82 0.0030
495 BONE DENSITY DECREASED 95 0.0030
496 DRUG LEVEL INCREASED 50 0.0030
497 WOUND INFECTION 33 0.0030
498 BLOOD TEST ABNORMAL 42 0.0030
499 DENTAL CARIES 33 0.0030
500 OROPHARYNGEAL PAIN 275 0.0030
501 PERIPHERAL SWELLING 456 0.0030
502 INTENTIONAL DOSE OMISSION 84 0.0029
503 TOOTH ABSCESS 30 0.0029
504 HYPONATRAEMIA 165 0.0029
505 ABNORMAL FAECES 24 0.0029
506 SMALL INTESTINAL OBSTRUCTION 36 0.0029
507 POLYNEUROPATHY 35 0.0029
508 EAR DISCOMFORT 30 0.0029
509 WHITE BLOOD CELL COUNT INCREASED 112 0.0029
510 NASOPHARYNGITIS 535 0.0029
511 EPISTAXIS 216 0.0029
512 ABSCESS 46 0.0029
513 OBSTRUCTIVE AIRWAYS DISORDER 32 0.0029
514 HEPATOTOXICITY 64 0.0029
515 BRONCHOSPASM 41 0.0029
516 HAEMOGLOBIN DECREASED 295 0.0029
517 DECREASED APPETITE 666 0.0029
518 APHONIA 40 0.0029
519 PHARYNGITIS STREPTOCOCCAL 31 0.0029
520 CONDITION AGGRAVATED 870 0.0029
521 ACUTE RESPIRATORY FAILURE 55 0.0029
522 DISTURBANCE IN ATTENTION 154 0.0029
523 VITREOUS FLOATERS 28 0.0028
524 HALLUCINATION 214 0.0028
525 MIDDLE INSOMNIA 53 0.0028
526 MUSCULAR WEAKNESS 322 0.0028
527 OEDEMA PERIPHERAL 345 0.0028
528 SCIATICA 45 0.0028
529 OVARIAN CYST 28 0.0028
530 VISION BLURRED 384 0.0028
531 COORDINATION ABNORMAL 39 0.0028
532 LOWER RESPIRATORY TRACT INFECTION 127 0.0028
533 ECZEMA 146 0.0028
534 HEART RATE IRREGULAR 63 0.0028
535 CARPAL TUNNEL SYNDROME 39 0.0028
536 PARANOIA 48 0.0028
537 BLOOD IRON DECREASED 33 0.0028
538 PETECHIAE 29 0.0028
539 SLEEP DISORDER 196 0.0028
540 MUSCLE STRAIN 24 0.0028
541 MUSCLE SPASMS 508 0.0028
542 PERICARDIAL EFFUSION 64 0.0028
543 BALANCE DISORDER 239 0.0028
544 PRESYNCOPE 67 0.0028
545 SPINAL PAIN 32 0.0027
546 NERVOUS SYSTEM DISORDER 85 0.0027
547 TOOTH FRACTURE 30 0.0027
548 GASTROOESOPHAGEAL REFLUX DISEASE 219 0.0027
549 BLADDER DISORDER 27 0.0027
550 RASH MACULAR 95 0.0027
551 TEMPERATURE INTOLERANCE 28 0.0027
552 BODY HEIGHT DECREASED 29 0.0027
553 NASAL CONGESTION 159 0.0027
554 KIDNEY INFECTION 53 0.0027
555 URINARY RETENTION 90 0.0027
556 VENTRICULAR EXTRASYSTOLES 28 0.0027
557 SWELLING FACE 175 0.0027
558 CHOLECYSTITIS 32 0.0027
559 CONTUSION 258 0.0027
560 PULMONARY OEDEMA 120 0.0027
561 HEART RATE DECREASED 94 0.0027
562 ALANINE AMINOTRANSFERASE INCREASED 164 0.0027
563 SKIN ULCER 69 0.0027
564 CYST 33 0.0027
565 MOTOR DYSFUNCTION 27 0.0026
566 EYE PRURITUS 89 0.0026
567 SKIN CANCER 57 0.0026
568 BURSITIS 32 0.0026
569 HIDRADENITIS 24 0.0026
570 BACK PAIN 611 0.0026
571 PULMONARY ARTERIAL HYPERTENSION 38 0.0026
572 PERIPHERAL COLDNESS 36 0.0026
573 BLISTER 147 0.0026
574 SENSORY DISTURBANCE 42 0.0026
575 DYSPHONIA 153 0.0026
576 STEVENS-JOHNSON SYNDROME 58 0.0026
577 NERVE INJURY 29 0.0026
578 LEUKOCYTOSIS 47 0.0026
579 DRUG ERUPTION 46 0.0026
580 FREQUENT BOWEL MOVEMENTS 70 0.0026
581 POLLAKIURIA 108 0.0026
582 ATELECTASIS 25 0.0026
583 EMOTIONAL DISTRESS 313 0.0026
584 ASCITES 76 0.0026
585 HYPERSOMNIA 74 0.0026
586 WEIGHT FLUCTUATION 27 0.0026
587 NAUSEA 2042 0.0026
588 DIZZINESS POSTURAL 25 0.0026
589 COGNITIVE DISORDER 120 0.0026
590 HAEMATURIA 88 0.0026
591 ROTATOR CUFF SYNDROME 33 0.0026
592 INTERVERTEBRAL DISC PROTRUSION 56 0.0026
593 WEIGHT DECREASED 715 0.0026
594 VERTIGO 156 0.0026
595 TOOTH LOSS 53 0.0026
596 JOINT STIFFNESS 67 0.0026
597 GENERAL PHYSICAL HEALTH DETERIORATION 295 0.0025
598 VENTRICULAR TACHYCARDIA 42 0.0025
599 DIPLOPIA 66 0.0025
600 BLOOD PRESSURE INCREASED 386 0.0025
601 HEPATIC STEATOSIS 47 0.0025
602 NEOPLASM 29 0.0025
603 HALLUCINATION, AUDITORY 40 0.0025
604 MIGRAINE 240 0.0025
605 HYPOMAGNESAEMIA 35 0.0025
606 PRODUCT TASTE ABNORMAL 34 0.0025
607 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
608 ANXIETY 711 0.0025
609 GINGIVAL BLEEDING 34 0.0025
610 PULMONARY MASS 37 0.0025
611 BLOOD PRESSURE DECREASED 165 0.0025
612 SKIN DISCOLOURATION 114 0.0025
613 GENERALISED TONIC-CLONIC SEIZURE 41 0.0025
614 HAEMORRHAGE INTRACRANIAL 37 0.0025
615 DYSURIA 91 0.0025
616 ASPARTATE AMINOTRANSFERASE INCREASED 131 0.0025
617 HEADACHE 1546 0.0025
618 TACHYCARDIA 219 0.0025
619 BLOOD PRESSURE ABNORMAL 49 0.0025
620 AUTOIMMUNE DISORDER 24 0.0025
621 HAEMORRHOIDS 48 0.0025
622 DRUG LEVEL DECREASED 25 0.0025
623 ULCER 39 0.0024
624 CYSTITIS 78 0.0024
625 FOETAL EXPOSURE DURING PREGNANCY 199 0.0024
626 RENAL DISORDER 114 0.0024
627 PSORIATIC ARTHROPATHY 99 0.0024
628 MASS 34 0.0024
629 RASH ERYTHEMATOUS 116 0.0024
630 ABDOMINAL DISTENSION 253 0.0024
631 FALL 806 0.0024
632 NEPHROLITHIASIS 111 0.0024
633 LIVER INJURY 59 0.0024
634 PULMONARY HYPERTENSION 50 0.0024
635 BACK DISORDER 39 0.0024
636 SINUS TACHYCARDIA 34 0.0024
637 DISCOMFORT 146 0.0024
638 RETCHING 51 0.0024
639 PRODUCT DOSE OMISSION 156 0.0024
640 GASTROINTESTINAL DISORDER 214 0.0024
641 HOT FLUSH 180 0.0024
642 ADVERSE DRUG REACTION 214 0.0024
643 PERICARDITIS 40 0.0024
644 BRAIN OEDEMA 30 0.0024
645 OSTEOMYELITIS 43 0.0024
646 HYPOTHERMIA 24 0.0024
647 HEAD INJURY 75 0.0024
648 INCONTINENCE 25 0.0024
649 ABDOMINAL PAIN 549 0.0024
650 RENAL PAIN 25 0.0024
651 SURGERY 138 0.0024
652 HEART RATE INCREASED 233 0.0023
653 TINNITUS 107 0.0023
654 OEDEMA 126 0.0023
655 ARTHRALGIA 965 0.0023
656 HAEMATOMA 60 0.0023
657 HYPERTENSION 490 0.0023
658 PAIN 1414 0.0023
659 BLOOD ALKALINE PHOSPHATASE INCREASED 57 0.0023
660 PARAESTHESIA ORAL 33 0.0023
661 LIVER FUNCTION TEST INCREASED 49 0.0023
662 COAGULOPATHY 38 0.0023
663 FLUID RETENTION 116 0.0023
664 BLOOD POTASSIUM INCREASED 37 0.0023
665 ERUCTATION 44 0.0023
666 UNEVALUABLE EVENT 172 0.0023
667 SWOLLEN TONGUE 71 0.0023
668 PNEUMOTHORAX 36 0.0023
669 MYOCARDITIS 26 0.0023
670 COMPLICATION OF DEVICE REMOVAL 41 0.0023
671 MULTIPLE FRACTURES 37 0.0022
672 METABOLIC ACIDOSIS 72 0.0022
673 THROAT IRRITATION 101 0.0022
674 HEREDITARY ANGIOEDEMA 24 0.0022
675 DRUG-INDUCED LIVER INJURY 70 0.0022
676 DRY MOUTH 181 0.0022
677 FEELING COLD 62 0.0022
678 WHEEZING 132 0.0022
679 EXPOSURE DURING PREGNANCY 138 0.0022
680 HYPOAESTHESIA 332 0.0022
681 GAIT DISTURBANCE 424 0.0022
682 TOOTHACHE 40 0.0022
683 UPPER LIMB FRACTURE 44 0.0022
684 JOINT SWELLING 266 0.0022
685 INFLUENZA LIKE ILLNESS 181 0.0022
686 HYPERGLYCAEMIA 80 0.0022
687 EYE DISORDER 72 0.0022
688 ACCIDENTAL OVERDOSE 80 0.0022
689 INSOMNIA 582 0.0022
690 GLAUCOMA 42 0.0022
691 PRODUCT USE IN UNAPPROVED INDICATION 536 0.0022
692 PARAESTHESIA 340 0.0022
693 URINARY INCONTINENCE 64 0.0022
694 ARTHROPATHY 120 0.0022
695 ORAL DISCOMFORT 30 0.0022
696 GAIT INABILITY 72 0.0022
697 ARTHRITIS 169 0.0021
698 PLATELET COUNT INCREASED 28 0.0021
699 DIZZINESS 1071 0.0021
700 MEMORY IMPAIRMENT 295 0.0021
701 HEAD DISCOMFORT 38 0.0021
702 VOMITING 1008 0.0021
703 HOSPITALISATION 328 0.0021
704 BLOOD CALCIUM DECREASED 24 0.0021
705 TREMOR 354 0.0021
706 NO THERAPEUTIC RESPONSE 26 0.0021
707 CARDIO-RESPIRATORY ARREST 89 0.0021
708 SWELLING 199 0.0021
709 PRESCRIBED OVERDOSE 41 0.0021
710 PRURITUS 812 0.0021
711 CENTRAL NERVOUS SYSTEM LESION 29 0.0021
712 PRODUCT AVAILABILITY ISSUE 48 0.0021
713 MYALGIA 358 0.0021
714 SPEECH DISORDER 110 0.0021
715 SKIN FISSURES 41 0.0021
716 DYSPEPSIA 206 0.0021
717 ERYTHEMA 429 0.0021
718 PNEUMONIA ASPIRATION 52 0.0021
719 DYSPNOEA 1178 0.0021
720 HAEMOPTYSIS 58 0.0021
721 SYNCOPE 208 0.0021
722 THROAT TIGHTNESS 56 0.0021
723 DRUG INTERACTION 328 0.0021
724 EATING DISORDER 44 0.0021
725 THERAPY CESSATION 106 0.0021
726 WEIGHT INCREASED 462 0.0021
727 SKIN EXFOLIATION 174 0.0021
728 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 370 0.0021
729 GASTRIC ULCER 39 0.0020
730 ABDOMINAL DISCOMFORT 344 0.0020
731 NEOPLASM PROGRESSION 71 0.0020
732 INTRAOCULAR PRESSURE INCREASED 26 0.0020
733 DYSPHAGIA 193 0.0020
734 LIVER DISORDER 90 0.0020
735 OSTEOARTHRITIS 86 0.0020
736 ABDOMINAL PAIN UPPER 417 0.0020
737 HEPATIC FAILURE 61 0.0020
738 HYPERSENSITIVITY 375 0.0020
739 GALLBLADDER DISORDER 36 0.0020
740 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 47 0.0020
741 PREMATURE DELIVERY 32 0.0020
742 HAIR COLOUR CHANGES 25 0.0020
743 HYPERLIPIDAEMIA 24 0.0020
744 HIATUS HERNIA 26 0.0020
745 DEVICE USE ISSUE 35 0.0020
746 LETHARGY 115 0.0020
747 PROTEINURIA 38 0.0020
748 SOMNOLENCE 402 0.0020
749 MOBILITY DECREASED 143 0.0020
750 MUSCULOSKELETAL STIFFNESS 174 0.0020
751 SCAR 34 0.0020
752 CEREBRAL HAEMORRHAGE 71 0.0020
753 TRANSAMINASES INCREASED 44 0.0020
754 VISUAL IMPAIRMENT 245 0.0020
755 ASTHMA 223 0.0020
756 DRY SKIN 262 0.0020
757 HEMIPARESIS 33 0.0019
758 PALPITATIONS 228 0.0019
759 HAIR TEXTURE ABNORMAL 26 0.0019
760 FEELING JITTERY 37 0.0019
761 LIMB DISCOMFORT 60 0.0019
762 AMNESIA 126 0.0019
763 HEPATIC ENZYME INCREASED 132 0.0019
764 URTICARIA 324 0.0019
765 THERAPEUTIC RESPONSE SHORTENED 64 0.0019
766 PRODUCT PRESCRIBING ISSUE 42 0.0019
767 PAIN IN EXTREMITY 567 0.0019
768 MUSCLE TIGHTNESS 31 0.0019
769 DEAFNESS 50 0.0019
770 BLOOD UREA INCREASED 32 0.0019
771 MUSCLE TWITCHING 44 0.0019
772 TREATMENT FAILURE 158 0.0019
773 THIRST 34 0.0019
774 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
775 OSTEONECROSIS OF JAW 47 0.0019
776 HIP FRACTURE 61 0.0019
777 CARDIOMYOPATHY 28 0.0019
778 LIP SWELLING 63 0.0019
779 MUSCULOSKELETAL DISORDER 36 0.0019
780 FEELING ABNORMAL 452 0.0019
781 DEPRESSION 429 0.0019
782 RENAL FAILURE ACUTE 80 0.0019
783 SNEEZING 42 0.0019
784 JOINT INJURY 40 0.0019
785 HERNIA 36 0.0019
786 WOUND 52 0.0019
787 MULTIPLE SCLEROSIS RELAPSE 127 0.0019
788 SKIN REACTION 26 0.0018
789 CHOKING 36 0.0018
790 CHEST DISCOMFORT 188 0.0018
791 THERAPEUTIC PRODUCT EFFECT DECREASED 82 0.0018
792 PREMATURE BABY 55 0.0018
793 ILL-DEFINED DISORDER 111 0.0018
794 AMENORRHOEA 32 0.0018
795 LOWER LIMB FRACTURE 35 0.0018
796 THYROID DISORDER 28 0.0018
797 HYPOTHYROIDISM 58 0.0018
798 MENTAL IMPAIRMENT 44 0.0018
799 DYSSTASIA 53 0.0018
800 RESPIRATORY DISORDER 54 0.0018
801 PALLOR 49 0.0018
802 INCORRECT PRODUCT ADMINISTRATION DURATION 39 0.0018
803 MALAISE 789 0.0018
804 EYE HAEMORRHAGE 24 0.0018
805 AGITATION 132 0.0018
806 GASTRITIS 47 0.0018
807 BLOOD CHOLESTEROL INCREASED 83 0.0018
808 CHEST PAIN 329 0.0018
809 IRRITABLE BOWEL SYNDROME 38 0.0018
810 FIBROMYALGIA 43 0.0018
811 DIALYSIS 25 0.0018
812 DRUG EFFECT LESS THAN EXPECTED 26 0.0018
813 LIVER FUNCTION TEST ABNORMAL 51 0.0018
814 DYSGEUSIA 130 0.0017
815 FLATULENCE 99 0.0017
816 UNRESPONSIVE TO STIMULI 45 0.0017
817 BURNING SENSATION 122 0.0017
818 DELUSION 27 0.0017
819 ACUTE MYOCARDIAL INFARCTION 51 0.0017
820 HYPERHIDROSIS 222 0.0017
821 COMA 82 0.0017
822 POST PROCEDURAL COMPLICATION 33 0.0017
823 THERAPEUTIC RESPONSE DECREASED 104 0.0017
824 PELVIC PAIN 31 0.0017
825 MATERNAL EXPOSURE DURING PREGNANCY 152 0.0017
826 BLINDNESS UNILATERAL 24 0.0017
827 PROCEDURAL PAIN 47 0.0017
828 SEIZURE 195 0.0017
829 DRUG INTOLERANCE 163 0.0017
830 EMOTIONAL DISORDER 52 0.0017
831 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 88 0.0017
832 IMPAIRED WORK ABILITY 36 0.0017
833 SLEEP APNOEA SYNDROME 32 0.0017
834 CARDIOGENIC SHOCK 24 0.0017
835 THERAPEUTIC RESPONSE UNEXPECTED 75 0.0017
836 ALOPECIA 328 0.0017
837 PRODUCT USE ISSUE 313 0.0017
838 MOOD SWINGS 53 0.0017
839 ANOSMIA 24 0.0017
840 RECTAL HAEMORRHAGE 71 0.0017
841 RESTLESS LEGS SYNDROME 30 0.0016
842 FEMUR FRACTURE 51 0.0016
843 MANIA 27 0.0016
844 MYELOSUPPRESSION 59 0.0016
845 JAUNDICE 44 0.0016
846 HIP ARTHROPLASTY 25 0.0016
847 LOSS OF CONSCIOUSNESS 209 0.0016
848 MUSCULOSKELETAL DISCOMFORT 28 0.0016
849 PAIN IN JAW 46 0.0016
850 INTESTINAL OBSTRUCTION 61 0.0016
851 FEELING HOT 99 0.0016
852 SHOCK 37 0.0016
853 RASH PAPULAR 36 0.0016
854 CARDIAC FAILURE CONGESTIVE 129 0.0016
855 TRANSIENT ISCHAEMIC ATTACK 54 0.0016
856 DEPRESSED LEVEL OF CONSCIOUSNESS 63 0.0016
857 MELAENA 35 0.0016
858 BLOOD TRIGLYCERIDES INCREASED 28 0.0016
859 BRADYCARDIA 84 0.0016
860 ABDOMINAL PAIN LOWER 40 0.0016
861 DRUG INEFFECTIVE 2075 0.0016
862 PANCREATITIS 82 0.0015
863 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 85 0.0015
864 BLINDNESS 63 0.0015
865 LUNG INFECTION 24 0.0015
866 LACTIC ACIDOSIS 50 0.0015
867 EPILEPSY 47 0.0015
868 FRACTURE 29 0.0015
869 NERVOUSNESS 80 0.0015
870 RESTLESSNESS 56 0.0015
871 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
872 ARRHYTHMIA 72 0.0015
873 KNEE ARTHROPLASTY 32 0.0015
874 ERECTILE DYSFUNCTION 39 0.0015
875 DEPRESSED MOOD 80 0.0015
876 RASH GENERALISED 39 0.0015
877 GASTRIC DISORDER 51 0.0015
878 ABNORMAL DREAMS 41 0.0015
879 VISUAL ACUITY REDUCED 49 0.0015
880 BLOOD URINE PRESENT 28 0.0015
881 GLOSSODYNIA 33 0.0015
882 MUSCULOSKELETAL PAIN 77 0.0015
883 PSORIASIS 190 0.0015
884 PRESCRIBED UNDERDOSE 29 0.0015
885 CONTRAINDICATED PRODUCT ADMINISTERED 44 0.0015
886 RENAL INJURY 43 0.0014
887 MOVEMENT DISORDER 46 0.0014
888 FAECES DISCOLOURED 31 0.0014
889 BONE DISORDER 26 0.0014
890 TREATMENT NONCOMPLIANCE 78 0.0014
891 GASTROINTESTINAL HAEMORRHAGE 119 0.0014
892 INJECTION SITE PRURITUS 95 0.0014
893 ROAD TRAFFIC ACCIDENT 59 0.0014
894 DIABETES MELLITUS 107 0.0014
895 DYSKINESIA 57 0.0014
896 ADVERSE EVENT 129 0.0014
897 ANAPHYLACTIC REACTION 77 0.0014
898 MOOD ALTERED 38 0.0014
899 PRODUCT PHYSICAL ISSUE 28 0.0014
900 FLUSHING 141 0.0014
901 HAEMATOCHEZIA 76 0.0014
902 DIABETIC KETOACIDOSIS 33 0.0014
903 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 97 0.0014
904 INTENTIONAL PRODUCT MISUSE 119 0.0014
905 RHEUMATOID ARTHRITIS 153 0.0013
906 MALIGNANT NEOPLASM PROGRESSION 138 0.0013
907 THINKING ABNORMAL 25 0.0013
908 HEPATIC FUNCTION ABNORMAL 50 0.0013
909 HAEMORRHAGE 140 0.0013
910 PAIN OF SKIN 36 0.0013
911 EXTRA DOSE ADMINISTERED 54 0.0013
912 CHROMATURIA 30 0.0013
913 TOXICITY TO VARIOUS AGENTS 224 0.0013
914 SYSTEMIC LUPUS ERYTHEMATOSUS 47 0.0013
915 DEATH 1140 0.0013
916 PANIC ATTACK 48 0.0013
917 SUICIDAL IDEATION 120 0.0013
918 IMPAIRED HEALING 43 0.0013
919 ANGINA PECTORIS 37 0.0013
920 DEVICE BREAKAGE 52 0.0013
921 INJECTION SITE RASH 39 0.0013
922 CEREBRAL INFARCTION 31 0.0013
923 INJECTION SITE REACTION 87 0.0013
924 MULTIPLE SCLEROSIS 60 0.0013
925 COLITIS ULCERATIVE 56 0.0013
926 IRRITABILITY 75 0.0012
927 CARDIAC ARREST 102 0.0012
928 NEOPLASM MALIGNANT 82 0.0012
929 GASTRIC CANCER 31 0.0012
930 ABORTION SPONTANEOUS 49 0.0012
931 INJECTION SITE URTICARIA 30 0.0012
932 OSTEONECROSIS 40 0.0012
933 INJECTION SITE SWELLING 93 0.0012
934 NIGHTMARE 42 0.0012
935 ANAPHYLACTIC SHOCK 31 0.0012
936 INCORRECT DOSE ADMINISTERED 274 0.0012
937 CHOLELITHIASIS 39 0.0012
938 CARDIAC DISORDER 111 0.0012
939 MENTAL DISORDER 51 0.0012
940 PRODUCT DISPENSING ERROR 25 0.0011
941 WITHDRAWAL SYNDROME 48 0.0011
942 INJECTION SITE BRUISING 91 0.0011
943 ACNE 85 0.0011
944 INJECTION SITE MASS 41 0.0011
945 RHABDOMYOLYSIS 46 0.0011
946 CRYING 40 0.0011
947 ANGER 37 0.0011
948 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 32 0.0011
949 HYPOACUSIS 47 0.0011
950 INJECTION SITE ERYTHEMA 135 0.0011
951 EXPOSURE VIA SKIN CONTACT 28 0.0011
952 MEDICATION ERROR 60 0.0011
953 CEREBROVASCULAR ACCIDENT 182 0.0011
954 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
955 UNDERDOSE 74 0.0010
956 AGGRESSION 50 0.0010
957 OVERDOSE 214 0.0010
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 201 0.0010
959 FEAR 26 0.0010
960 ABNORMAL BEHAVIOUR 38 0.0010
961 DEVICE DISLOCATION 41 0.0009
962 INJECTION SITE PAIN 287 0.0009
963 TYPE 2 DIABETES MELLITUS 31 0.0009
964 RESPIRATORY ARREST 24 0.0009
965 DRUG DOSE OMISSION 143 0.0009
966 CORONARY ARTERY DISEASE 26 0.0009
967 SKIN IRRITATION 39 0.0009
968 PSYCHOTIC DISORDER 25 0.0008
969 BLOOD GLUCOSE INCREASED 156 0.0008
970 EXPIRED PRODUCT ADMINISTERED 26 0.0008
971 INJECTION SITE HAEMORRHAGE 61 0.0008
972 MYOCARDIAL INFARCTION 129 0.0007
973 LUNG NEOPLASM MALIGNANT 30 0.0007
974 CONVULSION 41 0.0007
975 VAGINAL HAEMORRHAGE 31 0.0007
976 DRUG EFFECT DECREASED 36 0.0007
977 INJURY 46 0.0007
978 COMPLETED SUICIDE 54 0.0006
979 DEVICE ISSUE 58 0.0006
980 BREAST CANCER 56 0.0006
981 SKIN BURNING SENSATION 41 0.0006
982 NO ADVERSE EVENT 102 0.0006
983 ACCIDENTAL EXPOSURE TO PRODUCT 58 0.0006
984 PRODUCT STORAGE ERROR 49 0.0006
985 PROSTATE CANCER 45 0.0006
986 SUICIDE ATTEMPT 31 0.0005
987 HYPOGLYCAEMIA 24 0.0005
988 PRODUCT QUALITY ISSUE 67 0.0005
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
990 DRUG ABUSE 28 0.0003
991 DRUG DEPENDENCE 31 0.0002